Navigation Links
Glenmark Initiates Phase 2 Trial for Crofelemer for Acute Infectious Diarrhea
Date:12/6/2007

molecules. Glenmark has 11 lead molecules at various stages of development in NCE & NBE research. Three of the leads are in Phase 2 whereas eight other leads are into the pre-clinical and discovery stages in the broad areas of inflammation and metabolic disorders.

The Company has generic formulation and API business interests in over 80 countries across the world including the highly regulated markets of USA and Europe. The formulation business spans several product segments such as Dermatology, Internal Medicine, Pediatrics, Gynecology, ENT, Cardiology, Diabetes and Oncology.

Glenmark's first Asthma/COPD molecule, Oglemilast [GRC 3886], was licensed out to Forest Laboratories and Teijin Pharma Limited for the North American and Japanese markets, respectively, in two landmark deals. The Company's second lead GRC 8200, a DPP-IV inhibitor for Type II Diabetes was out-licensed to Merck KGaA, Germany for the North American, European and Japanese markets. A third molecule targeting pain, GRC 6211, undergoing Phase 2 clinical trials in Europe, has recently been out-licensed to Eli Lilly & company.

For further information, please contact:

Ms. Vasudha Jha

General Manager, Corporate Communications

Glenmark Pharmaceuticals Ltd.

Tel: [+91 22] 40189919 | Fax: [+91 22] 40189986

Email: media@glenmarkpharma.com

http://www.glenmarkpharma.com

About Crofelemer

Crofelemer, a proprietary patented agent, is extracted from Croton lechleri, a medicinal plant which can be sustainably harvested from several countries in South America. Crofelemer is in various stages of clinical development for four distinct product indications, one in Phase 3, two in Phase 2 and one in Phase 1.

Crofelemer has been tested in trials involving approximately 1500 patients in double-blind placebo-controlled, mostly published t
'/>"/>

SOURCE Napo Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lilly and Glenmark Pharmaceuticals Announce License Agreement
2. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
7. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
8. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. Prolexys Pharmaceuticals Initiates Phase 1 Study
11. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... CLARA, Calif. , July 30, 2014 ... economy, released a study today that examines ... biopharma and medical device companies.  According to the annual ... saw the biggest potential returns since SVB started tracking ... year of the IPO.  Built on solid healthcare M&A ...
(Date:7/30/2014)... , July 30, 2014  Lightlake Therapeutics Inc. ... treatments based on its expertise in opioid antagonists, ... commitment from a prominent international research and development ... on promoting innovative research-based initiatives, including those addressing ... spray for the delivery of naloxone that could ...
(Date:7/30/2014)... 2014   Epic Sciences, Inc. ("Epic"), ... develops novel diagnostics to personalize and advance the ... completion of a $30 million Series C Preferred ... (RMI) and Arcus Ventures, existing investors Domain Associates, ... well as undisclosed individual investors. With the proceeds ...
Breaking Medicine Technology:Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 2Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 3Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 2Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 3
... Inc. (NYSE: HSP ), a leading global specialty ... will present at the Morgan Stanley Global Healthcare Conference on ... presentation is scheduled to begin at 8:35 a.m. Eastern time ... all interested parties through a live audiocast accessible via the ...
... Wright Therapy Products, Inc. announced today that ... Executive Officer of the company.  The company, based ... devices targeted for the treatment of lymphedema, venous ... Wright Therapy after holding senior financial and sales ...
Cached Medicine Technology:Industry Leaders Hinson and Friel Join Wright Therapy Products 2
(Date:7/30/2014)... Angeles, CA (PRWEB) July 30, 2014 ... the Chao Pinhole Surgical Technique®, the revolutionary minimally invasive ... Dennis Shanelec, considered by many of his peers to ... special guest speaker at a recent Chao Pinhole Surgical ... Alhambra, CA. Dr. Shanelec is the recipient of the ...
(Date:7/30/2014)... DC (PRWEB) July 30, 2014 ... appreciation to U.S. Sens. Thad Cochran (R-MS) and ... for improvements in telemedicine coverage under Medicare, Medicaid ... and Wicker, both Mississippi Republicans, introduced the Telehealth ... to a House version, H.R. 3306, introduced by ...
(Date:7/30/2014)... 2014 The Institute for Integrative Nutrition ... announce that Arianna Huffington has joined as a guest speaker ... Health Coach Training Program . , Arianna Huffington is the ... news and blogging site that won a Pulitzer Prize in ... books and was included on the Forbes “Most Powerful Women” ...
(Date:7/30/2014)... 2014 Frozen shoulder (Adhesive capsulitis) affects 10-20 ... develop this nasty condition which occurs most frequently in people ... up to two and half years if not treated. , ... with good reason: it can render your shoulder so stiff, ... if you aren't in too much pain to get dressed ...
(Date:7/30/2014)... HealthDay Reporter WEDNESDAY, July 30, 2014 (HealthDay ... the agitation that commonly strikes people with dementia, a new ... found evidence that watering plants, or sitting or strolling in ... The study authors cautioned that the effects of gardens on ... the evidence of a benefit is limited. But experts said ...
Breaking Medicine News(10 mins):Health News:Periodontist Dr. Dennis Shanelec Comments On The Chao Pinhole Surgical Technique® Training Course 2Health News:ATA Applauds Senators’ Push for Federal Telemedicine Improvements 2Health News:Arianna Huffington Joins Integrative Nutrition as a Guest Speaker 2Health News:Arianna Huffington Joins Integrative Nutrition as a Guest Speaker 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 2Health News:Good News for Diabetics Suffering from Frozen Shoulder 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 4Health News:Gardens a Center of Calm for People With Dementia 2Health News:Gardens a Center of Calm for People With Dementia 3
... Denver, Colorado (June 1, 2011) Five advocacy organizations ... granted travel awards by the International Association for the ... the 14th World Conference on Lung Cancer, July 3-7 ... Australian Lung Foundation (Australia): The Australian Lung Foundation is ...
... (HealthDay News) -- Age alone should not be the sole determining ... a new study suggests. In following 216 women over the ... if screened properly, people who have facelifts after age 65 are ... , , More than 12 percent of the U.S. ...
... , WEDNESDAY, June 1 (HealthDay News) -- Boys ... significantly higher risk of developing a substance abuse problem ... "Our study, which is one of the largest ... supports the association between ADHD and substance abuse ...
... American Society for Gastrointestinal Endoscopy (ASGE) and the ... updated their 2003 joint guideline for reprocessing gastrointestinal ... account evolved technology and disinfection systems. ... in collaboration with multiple physician and nursing organizations, ...
... anticancer chemotherapeutics. However, it has some severe side effects ... the kidneys. Understanding the mechanisms underlying this toxicity could ... with cisplatin to protect the kidney during chemotherapy. In ... Dong, at Georgia Health Sciences University, Augusta, has now ...
... Dana-Farber Cancer Institute have identified an overactive network ... cells enriched in triple-negative breast tumors, a typically ... therapies. Kornelia Polyak, MD, PhD, a breast ... a large proportion of cells within these tumors ...
Cached Medicine News:Health News:5 advocacy organizations win travel awards to attend World Conference on Lung Cancer in Amsterdam 2Health News:5 advocacy organizations win travel awards to attend World Conference on Lung Cancer in Amsterdam 3Health News:Plastic Surgery Risks May Depend on More Than Age 2Health News:Children With ADHD More Prone to Substance Abuse: Study 2Health News:ASGE and SHEA issue updated multisociety guideline on reprocessing flexible gastrointestinal endoscopes 2Health News:ASGE and SHEA issue updated multisociety guideline on reprocessing flexible gastrointestinal endoscopes 3Health News:ASGE and SHEA issue updated multisociety guideline on reprocessing flexible gastrointestinal endoscopes 4Health News:Scientists identify overactive genes in aggressive breast cancers 2
... Oxylab pO2 probes feature response ... seconds for real-time monitoring of ... Oxylab LDFTM, measurements of pO2, ... be obtained from the same ...
Spherical Burr for FR030R, 5 mm....
Tungsten Carbide Burr "HM", 0,7 mm, ISO-No. 007....
"Rosen" burr, 0,7 mm, ISO-No. 007....
Medicine Products: